Coagulation inhibitors in alcoholic liver cirrhosis

Alcohol
J M Raya-SánchezA Martínez-Riera

Abstract

In the present study we have analyzed the relationship between coagulation inhibitors (antithrombin III, protein C and S, thrombomodulin), liver function impairment, and plasma activity of the endothelium-derived proteins plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in 27 alcoholic cirrhotic patients and 25 controls. Cirrhotics showed decreased values of all the mentioned parameters except for thrombomodulin, PAI-1, and t-PA. Thrombomodulin and t-PA levels were higher in cirrhotics. No relationship was observed between thrombomodulin and t-PA or PAI-1. Protein C and antithrombin III levels were significantly lower in Child's C patients, whereas no correlation was found between t-PA and thrombomodulin and hepatic function derangement. PAI-1 activity was normal in our patients.

References

Mar 1, 1992·Journal of Hepatology·H BellN Raknerud
Apr 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F VioliF Balsano
May 1, 1992·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·J W van WerschF A Lustermans
Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C Infante-RivardJ P Villeneuve
Jan 1, 1993·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·V ToschiA Gibelli

❮ Previous
Next ❯

Citations

Aug 19, 2009·Journal of Gastroenterology and Hepatology·Donglei ZhangNing Yang
Feb 15, 2013·Anesthesia and Analgesia·Alan Finley, Charles Greenberg
Mar 27, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shun KohsakaKeiichi Fukuda
Apr 21, 2004·Journal of the American Academy of Dermatology·Severine M ChavelJeffrey S Schechner
Mar 11, 2015·Journal of Clinical and Experimental Hepatology·Kaiser RajaSonal Asthana
May 27, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Aida SarayMehmedović Amila
Mar 16, 2018·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Gülsüm ÖzkanBurhan Turgut
Apr 29, 2018·International Journal of Laboratory Hematology·A G PatilS K Sarin
May 13, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Abeer Khalid Al GhumlasFaleh Zaid Al Faleh
Dec 19, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Ayman A AbdoAbdel Galil Abdel Gader
Jun 23, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Abeer K Al GhumlasFaleh Z Al Faleh
May 18, 2016·World Journal of Gastroenterology : WJG·Emilio González-ReimersFrancisco Santolaria-Fernández
Jan 31, 2002·World Journal of Gastroenterology : WJG·J G FanM D Zeng
Jun 8, 2017·Journal of Investigative Medicine High Impact Case Reports·Natasha ShahRogelio Silva
Jan 20, 2009·Clinics in Liver Disease·Dougald M Monroe, Maureane Hoffman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.